Oncology Business Review
The economics of the oncology industry have never been better, but changes are looming. A confluence of market forces is adjusting the commercial equation for oncology companies, rendering them potential victims of their own success. Pamela Santoni and Thomas Foster of IMS Health consider the unintended consequences of progress.
Click here for the full pdf article.